NCT05169073 Virtual Reality Training for Laparoscopic Cholecystectomy
| NCT ID | NCT05169073 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Virtual Reality |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2021-11-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2021-11-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cholecystectomy is one the most frequent laparoscopic procedures worldwide. It is a safe and effective operation but intraoperative bile duct injury remains a relevant complication with serious consequences for the patient. Most of the complications occur due to a lack of knowledge of the anatomy or misidentification of the cystic duct. Thus, the study of the anatomy is a cornerstone of a successful procedure and the preoperative magnetic resonance cholangiopancreatography (MRCP) is a way to preoperatively determine relevant structures to avoid intraoperative incidents. This trial has been designed to assess the effect of preoperative virtual reality training based on MRCP on intraoperative performance and outcome.
Eligibility Criteria
Inclusion Criteria: * Referred for elective cholecystectomy for symptomatic cholecystolithiasis/chronic cholecystitis * Early cholecystectomy after acute biliary pancreatitis * Concomitant minor procedures (adhesiolysis, umbilical hernia repair, liver biopsy) * Sufficient quality of MRCP Exclusion Criteria: * American Society of Anaesthesiologists (ASA) classification ≥ 4 * Previous major open upper abdominal surgery * Suspicion for concomitant biliary disease (e.g. Mirizzi-Syndrome) * Robotic cholecystectomy * Planned open procedures
Contact & Investigator
Sebastian Staubli, MD
PRINCIPAL INVESTIGATOR
Clarunis - University Center for Gastrointestinal and Liver Diseases
Frequently Asked Questions
Who can join the NCT05169073 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, up to 45 Years, studying Virtual Reality. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05169073 currently recruiting?
Yes, NCT05169073 is actively recruiting participants. Contact the research team at christoph.kuemmerli@clarunis.ch for enrollment information.
Where is the NCT05169073 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT05169073 clinical trial?
NCT05169073 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Sebastian Staubli, MD at Clarunis - University Center for Gastrointestinal and Liver Diseases. The trial plans to enroll 20 participants.